Cargando…
S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
Pancreatic cancer (PC) is a highly fatal and aggressive disease with its incidence and mortality quite discouraging. It is of great significance to construct an effective prognostic signature of PC and find the novel biomarker for the optimization of the clinical decision-making. Due to the crucial...
Autores principales: | Chen, Yuan, Wang, Chengcheng, Song, Jianlu, Xu, Ruiyuan, Ruze, Rexiati, Zhao, Yupei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650155/ https://www.ncbi.nlm.nih.gov/pubmed/34887861 http://dx.doi.org/10.3389/fimmu.2021.758004 |
Ejemplares similares
-
Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer
por: Wang, Chengcheng, et al.
Publicado: (2022) -
Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer
por: Song, Jianlu, et al.
Publicado: (2022) -
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review
por: Ruze, Rexiati, et al.
Publicado: (2023) -
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
por: Chen, Yuan, et al.
Publicado: (2021) -
SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway
por: Xu, Ruiyuan, et al.
Publicado: (2023)